Chow Gregory K. 4
4 · Aptose Biosciences Inc. · Filed Jul 10, 2020
Insider Transaction Report
Form 4
Chow Gregory K.
Senior VP & CFO
Transactions
- Sale
Common Shares
2020-07-10$6.05/sh−126,668$766,341→ 232,846 total
Footnotes (1)
- [F1]Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of 225,000 restricted stock units, previously reported on a Form 4/A filed with the Securities and Exchange Commission on March 10, 2020.